Paper39903363
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.
Chen W and 2 others. Curr HIV/AIDS Rep, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places. Papers, record 39903363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39903363
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| HIV Infections | Major topic |
| Virus Latency | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Disease Reservoirs | Major topic |
| Humans | |
| Phenotype | |
| Proviruses |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 09120011910035 | Dutch Medical Research Council (ZonMw) | PubMed | ||
| 1110680-77-RPRL | amfAR, The Foundation for AIDS Research | PubMed | ||
| KICH2.V4P.AF23.001 | Partnership NWO-Dutch AIDS Fonds 'HIV cure for everyone' | PubMed |
Source PubMed
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24152939 | The end of AIDS: HIV infection as a chronic disease. | Lancet | 2013 | https://conductscience.org/library/papers/24152939 | PubMed |
| 2 | 9144289 | Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. | Nature | 1997 | https://conductscience.org/library/papers/9144289 | PubMed |
| 3 | 9360927 | Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. | Science | 1997 | https://conductscience.org/library/papers/9360927 | PubMed |
| 4 | 12754504 | Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. | Nat Med | 2003 | https://conductscience.org/library/papers/12754504 | PubMed |
| 5 | 25877550 | Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. | J Infect Dis | 2015 | https://conductscience.org/library/papers/25877550 | PubMed |
| 6 | 19543283 | HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. | Nat Med | 2009 | https://conductscience.org/library/papers/19543283 | PubMed |
| 7 | 24968937 | HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. | Science | 2014 | https://conductscience.org/library/papers/24968937 | PubMed |
| 8 | 25011556 | HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. | Science | 2014 | https://conductscience.org/library/papers/25011556 | PubMed |
| 9 | 16775332 | Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. | J Virol | 2006 | https://conductscience.org/library/papers/16775332 | PubMed |
| 10 | 26858442 | Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26858442 | PubMed |
| 11 | 30446650 | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. | Nat Commun | 2018 | https://conductscience.org/library/papers/30446650 | PubMed |
| 12 | 26814962 | Persistent HIV-1 replication maintains the tissue reservoir during therapy. | Nature | 2016 | https://conductscience.org/library/papers/26814962 | PubMed |
| 13 | 34387543 | Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy. | Elife | 2021 | https://conductscience.org/library/papers/34387543 | PubMed |
| 14 | 27078619 | Persistent HIV-1 replication during antiretroviral therapy. | Curr Opin HIV AIDS | 2016 | https://conductscience.org/library/papers/27078619 | PubMed |
| 15 | 24243014 | Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. | Cell | 2013 | https://conductscience.org/library/papers/24243014 | PubMed |
| 16 | 27500724 | Defective proviruses rapidly accumulate during acute HIV-1 infection. | Nat Med | 2016 | https://conductscience.org/library/papers/27500724 | PubMed |
| 17 | 29045846 | Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. | Cell Rep | 2017 | https://conductscience.org/library/papers/29045846 | PubMed |
| 18 | 30760706 | Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. | Nat Commun | 2019 | https://conductscience.org/library/papers/30760706 | PubMed |
| 19 | 36596305 | Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. | Cell Host Microbe | 2023 | https://conductscience.org/library/papers/36596305 | PubMed |
| 20 | 35026153 | Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses. | Cell | 2022 | https://conductscience.org/library/papers/35026153 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42515607 | Ebola Virus Persistence Beyond Acute Infection: Could HIV-Associated Immune Dysfunction Influence Survivor Biology? | Viruses | 2026 | https://conductscience.org/library/papers/42515607 | PubMed |
| 42139147 | Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control. | Curr Opin HIV AIDS | 2026 | https://conductscience.org/library/papers/42139147 | PubMed |
| 41772600 | TARDBP as a regulator of HIV-1 assembly and infection: a review of targeting the viral capsid precursor Pr55Gag and limiting viral core entry. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41772600 | PubMed |
| 41754496 | Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV. | Viruses | 2026 | https://conductscience.org/library/papers/41754496 | PubMed |
| 41729081 | Single-cell capture of on-ART SIV transcription reveals TGF-β-mediated metabolic control of viral latency. | JCI Insight | 2026 | https://conductscience.org/library/papers/41729081 | PubMed |
| 40943350 | Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943350 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| FCGR2A | 2212 | PubTator's text mining | https://conductscience.org/library/genes/2212 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39903363
GET https://conductscience.org/api/papers/v1/39903363/references?page=2